Novavax's COVID vaccine recommended by CDC for children aged 12 through 17
August 22, 2022 at 15:13 PM EDT
Novavax's protein-based Coronavirus vaccine has been recommended by the US CDC for adolescents aged 12-17 years old after receiving emergency use authorization for adults in June.